Picture [LSA] – The Business Web Portal 650x89px
Organisation › Details

Leo Pharma A/S

LEO Pharma is specialised in dermatology (primarily psoriasis and skin infections) and critical care (hemostasis and nephrology). In 2005 LEO Pharma had revenues of MEUR 652 with profit before tax of MEUR 337. The equity position in 2005 was MEUR 1,741. LEO Pharma is a Pan-European company with subsidiaries in most European countries as well as in Canada, Middle East, Far East and Latin America. LEO Pharma products are sold in 90 countries and the company employs 3,000 people. LEO Pharma is 100% owned by the LEO Foundation. The sole purpose of the Foundation is to run LEO Pharma as an independent pharmaceutical company *


Period Start 1990-01-01 existent
Period End 1994-07-01 existent
  Group Leo Pharma (Group)
Products Industry pharmaceutical
  Industry 2 dermatic
Persons Person Aabo, Gitte (Leo Pharma 201511 CEO)
  Person 2 Kronborg, Anders (Leo Pharma 201510– EVP Global Finance, IT + Legal before Kinnevik Investment AB)
Region Region Ballerup
  Country Denmark
  Street 55 Industriparken
  City 2750 Ballerup
  Tel +45-44-945888
    Address record changed: 2018-07-24
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2019-07-06


Picture [LSA] – The Business Web Portal 650x89px

More documents for Leo Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px

» top